|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Children's Nutritional Research Center, Baylor College of Medicine, Houston, Texas, United States
2 USDA Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States
* To whom correspondence should be addressed. E-mail: dburrin{at}bcm.tmc.edu.
We previously demonstrated the dose-dependent GLP-2 activation of intracellular signals associated with increased epithelial cell survival and proliferation in the neonatal intestine. Our current aim was to quantify the acute, temporal GLP-2 activation of these key intracellular signals and relate this to changes in epithelial cell survival and proliferation in the neonatal intestine. We studied twenty-nine TPN-fed neonatal piglets infused intravenously with either saline (control) or human GLP-2 (415 µmol·kg-1·h-1) for 1, 4 or 48 h. GLP-2 infusion increased small intestinal weight, DNA and protein content, and villus height at 48 h, but not at 1 or 4 h. Intestinal crypt and villus apoptosis decreased and crypt cell proliferation and protein synthesis increased linearly with duration of GLP-2 infusion, but were statistically different from controls only after 48 h. Prior to the morphological and cellular kinetic changes, GLP-2 rapidly activated putative GLP-2R downstream signals within 1-4 h, including phosphorylation of PKA, PKB, ERK1/2 and the transcription factors CREB and c-Fos. GLP-2 rapidly suppressed caspase-3 activation and upregulated Bcl-2 abundance within 1 h, whereas there was an increase in apoptosis inhibitors, XIAP at 1 h and cIAP-2 at 4 and 48 h. We also show that the increased c-Fos and reduced active caspase-3 immunostaining after GLP-2 infusion was localized in epithelial cells. We conclude that GLP-2-induced activation of intracellular signals involved in both cell survival and proliferation occurs rapidly and precedes the trophic cellular kinetic effects that occur later in intestinal epithelial cells.
This article has been cited by other articles:
![]() |
P. E. Dube and P. L. Brubaker Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E460 - E465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |